Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-08-13 Ho Carole Chief Medical Officer Sale 10b5-1 −806 $14.64 $12K 216,585
2025-08-12 Ho Carole Chief Medical Officer Sale 10b5-1 −2,937 $13.58 $40K 217,391
2025-08-05 Ho Carole Chief Medical Officer Option exercise +44,655 $0.68 $30K 220,328
2025-08-05 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −44,655 62,500
2025-01-07 Ho Carole Chief Medical Officer Sale −2,907 $20.81 $60K 175,673
2025-01-06 Ho Carole Chief Medical Officer Sale −12,255 $20.22 $248K 178,580
2025-01-03 Ho Carole Chief Medical Officer Grant or award +54,180 190,835
2025-01-03 Ho Carole Chief Medical Officer Grant or award · Stock Option (right to buy) +162,540 162,540
2024-11-25 Ho Carole Chief Medical Officer Option exercise +17,845 $0.68 $12K 136,655
2024-11-25 Ho Carole Chief Medical Officer Option exercise · Stock Option (right to buy) −17,845 107,155
2024-08-21 Ho Carole Chief Medical Officer Sale 10b5-1 −14,098 $24.41 $344K 124,717
2024-08-21 Ho Carole Chief Medical Officer Sale 10b5-1 −5,907 $24.96 $147K 118,810
2024-08-20 Ho Carole Chief Medical Officer Sale 10b5-1 −2,453 $23.79 $58K 138,815
2024-08-13 Ho Carole Chief Medical Officer Sale −2,337 $22.89 $53K 141,268
2024-02-14 Ho Carole Chief Medical Officer Sale 10b5-1 −1,405 $17.79 $25K 143,605
2024-02-13 Ho Carole Chief Medical Officer Sale 10b5-1 −2,784 $17.29 $48K 145,010
2024-01-10 Ho Carole Chief Medical Officer Sale 10b5-1 −4,668 $19.02 $89K 147,794
2024-01-05 Ho Carole Chief Medical Officer Sale −9,972 $19.43 $194K 198,777
2024-01-03 Ho Carole Chief Medical Officer Grant or award +53,720 162,434
2024-01-03 Ho Carole Chief Medical Officer Grant or award · Stock Option (right to buy) +161,160 161,160

Page 1 of 11 · 210 trades